- RSV in Adults: A Hidden Annual Epidemic
- RSV Manifestations in Adult Patients
- Questions and Answers
Angela Branche, MD
Associate Professor of Medicine
Division of Infectious Diseases
Department of Medicine
University of Rochester
Rochester, New York
Helen Y. Chu, MD, MPH
Division of Allergy & Infectious Diseases
University of Washington School of Medicine
The goal of this activity is to improve learners’ awareness of RSV infections in adults including epidemiology, burden of disease, pathophysiology, clinical presentations, and risk factors for severity.
This program is intended for US-based physicians, nurse practitioners, pharmacists, and other healthcare professionals who care for adults at risk for severe RSV infection, including both specialists and primary care providers. This identified target audience will benefit from this education by increasing awareness of the hidden annual epidemic of RSV in adults.
Upon completion of this activity, participants should be able to:
- Learners will increase their awareness of the prevalence and implications (morbidity/mortality and healthcare burden) of RSV disease in adults including the potential benefits of emerging vaccines.
Joint Accreditation Statement
In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Physician Continuing Medical Education
Designation of Credit
CCO designates this live activity for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 0.75 contact hours.
Continuing Pharmacy Education
CCO designates this continuing education activity for 0.75 contact hours (0.075 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number: JA4008176-0000-23-016-L01-P
Type of Activity: Knowledge
Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.
Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.